Select the search type
  • Site
  • Web


Winter 2011 issue:

Aortic Valve Replacement

Inoperable patients with severe symptomatic aortic stenosis have survival rates as low as 50 percent within two years of symptom onset. A team of Washington University cardiac surgeons and interventional cardiologists at Barnes-Jewish Hospital has developed unique expertise in a new technology— percutaneous aortic valve replacement— that makes AVR an option for these highrisk patients.

Also in this issue:

Download the full pdf of Winter 2011

Sign Up Today for Free e-Newsletters

Get the latest in medical technology, research and disease prevention sent to your inbox.
Find a doctor or make an appointment: 855.925.0631
General Information: 314.747.3000
One Barnes-Jewish Plaza
St. Louis, MO 63110
© Copyright 1997-2021, Barnes-Jewish Hospital. All Rights Reserved.